The triglyceride-glucose (TyG) index has been identified as a reliable alternative biomarker of insulin resistance (IR). To this end, in this review, we summarize the history of the use of the TyG index as a surrogate marker for IR.
Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.
Read the full paper
Access the original peer-reviewed research via OpenAlex.
| Category | 🧬 Medicine & Biology |
| Published | May 06, 2022 |
| Journal | Cardiovascular Diabetology |
| Authors | Lichan Tao, Jiani Xu, Tingting Wang, Fei Hua, Jian‐Jun Li |
| DOI | 10.1186/s12933-022-01511-x |
| Citations | 1,073 |
| Source | OpenAlex |